Whitepapers

Endometriosis is a chronic inflammatory disease that remains widely underdiagnosed and underfunded, despite affecting nearly 190 million women worldwide. This paper examines how historical neglect, diagnostic delays, and limited treatment innovation have contributed to persistent gaps in care, while also highlighting emerging progress in non‑invasive diagnostics, evolving clinical guidelines, and renewed policy momentum.

Drawing on clinical literature, recent policy developments, and patient‑reported insights from a Healogix consumer survey, this white paper outlines where the system has fallen short and what it will take to align science, clinical practice, and policy to drive meaningful change for people living with endometriosis.

Modernizing Endometriosis – An Ancient Disease Still Waiting for Advanced Solutions

Perimenopause is finally stepping into the spotlight as changing cultural attitudes, increasing patient advocacy, and heightened demand for better care elevate the conversation. Yet many women still face inconsistent guidance, stigmatized conversations, and gaps in treatment options. Drawing on proprietary Healogix research and behavioral science, this paper explores how perceptions are shifting across generations, the impact of the Women’s Health Initiative (WHI) results from 2002, and emerging hormonal and non-hormonal therapies. It also identifies opportunities for pharma, healthcare providers, and policymakers to advance education, innovation, and access for women seeking more informed care and better support during this midlife transition.

Empowering Perimenopause – Breaking the Silence, Reshaping the Narrative, and Driving the Change

Humans navigate complex decision-making processes, often dealing with conflicting information and desires.  Read about how the Healogix Behavioral Science Team conducted a two-wave study to explore how decision-making conflicts arise and resolve in the context of a high-stakes decision, specifically predicting voter behavior in the 2024 U.S. Presidential Election.

Predicting Healthcare Policy Preferences In The 2024 U.S. Presidential Election